BDSX Insider Trading Activity and SEC Form 4 Filings
BDSX insider trading summary
Over the past 12 months, insiders at Biodesix Inc (BDSX) reported 15 sales worth $76K by 5 insiders and 6 open-market purchases worth $3.1M by 1 insider on SEC Form 4. Net insider buying was $3.0M.
Latest BDSX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 12, 2026 | Jack W Schuler | Insider | Buy | $367K (15,000 @ $24.47) |
| Aug 11, 2026 | Jack W Schuler | Insider | Buy | $329K (13,700 @ $24.01) |
| Aug 10, 2026 | Jack W Schuler | Insider | Buy | $337K (13,900 @ $24.25) |
| Feb 10, 2026 | Robin Harper Cowie | CFO, Sec'y & Treasurer | Sell | $9K (941 @ $10.08) |
| Feb 10, 2026 | Gary Anthony Pestano | Chief Development Officer | Sell | $5K (540 @ $10.08) |
| Feb 10, 2026 | Scott Hutton | President & CEO | Sell | $36K (3,559 @ $10.08) |
| Feb 10, 2026 | Chris Vazquez | Chief Accounting Officer | Sell | $1K (101 @ $10.08) |
| Feb 10, 2026 | Kieran O'Kane | Chief Commercial Officer | Sell | $6K (584 @ $10.08) |
| Jan 26, 2026 | Jack W Schuler | Insider | Buy | $236K (20,000 @ $11.80) |
| Jan 23, 2026 | Jack W Schuler | Insider | Buy | $945K (80,000 @ $11.81) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.